Contacts

France : EIB and MedinCell sign a new €40 million loan agreement to support development of innovative treatments 

November 23, 2022

Download press release
  • The 40 million euros loan is intended for the development of treatments based on MedinCell’s proprietary long-acting injectable technology aiming at significantly enhance patient care and quality of life
  • This EIB investment is guaranteed by the European Fund for Strategic Investments, the central pillar of the Investment Plan for Europe 
  • This release follows an initial publication on 5 September 2022 (available here)

    Details of the loan agreement are available here

Session en français

Rendez-vous le mardi 12 septembre à 18h00 pour la diffusion en direct de l'Assemblée Générale mixte

English session

On Tuesday September 12 at 6:00 p.m. live of the Combined General Meeting (in French)

Êtes-vous un actionnaire de MedinCell ? / Are you a MedinCell shareholder?
Vous êtes / You are :
This field is for validation purposes and should be left unchanged.

CONTACT

  • This field is for validation purposes and should be left unchanged.